Loading
A phase 3 trial of Bleomycin and Talc in Metastatic cancer, run by Eastern Cooperative Oncology Group, completed.
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions is a phase 3 interventional study registered as NCT00002872 by Eastern Cooperative Oncology Group, with 480 participants recorded, started 1997-01-10 and reaching its primary completion in 2003-02. Interventions recorded: bleomycin sulfate, doxycycline, talc. Conditions recorded: Metastatic Cancer.
Linked to the drug Talc because the registry names it among its interventions and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.
Shares Talc (intrapleural), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Talc (intrapleural), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Bleomycin and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.